Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 180

1.

Patterns of initially overlooked recurrence of peritoneal lesions in patients with advanced ovarian cancer on postoperative multi-detector row CT.

Bae H, Jung DC, Lee JY, Nam EJ, Kang WJ, Oh YT.

Acta Radiol. 2019 May 12:284185119842832. doi: 10.1177/0284185119842832. [Epub ahead of print]

PMID:
31081339
2.

Development and Validation of an 18 F-Fluorodeoxyglucose-Positron Emission Tomography With Computed Tomography-Based Tool for the Evaluation of Joint Counts and Disease Activity in Patients With Rheumatoid Arthritis.

Lee SJ, Jeong JH, Lee CH, Ahn BC, Eun JS, Kim NR, Kang JW, Nam EJ, Kang YM.

Arthritis Rheumatol. 2019 Feb 16. doi: 10.1002/art.40860. [Epub ahead of print]

PMID:
30771237
3.

Adenosine triphosphate-based chemotherapy response assay predicts long-term survival of primary epithelial ovarian cancer.

Li LY, Kim SW, Nam EJ, Lee J, Kim S, Kim YT.

Int J Gynecol Cancer. 2019 Feb;29(2):334-340. doi: 10.1136/ijgc-2018-000058. Epub 2019 Jan 4.

PMID:
30718314
4.

Mediating Effects of Social Support on Depression and Suicidal Ideation in Older Korean Adults With Hypertension Who Live Alone.

Nam EJ, Lee JE.

J Nurs Res. 2019 Jun;27(3):e20. doi: 10.1097/jnr.0000000000000292.

PMID:
30694222
5.

Pretreatment lymphocytopenia is an adverse prognostic biomarker in advanced-stage ovarian cancer.

Lee YJ, Chung YS, Lee JY, Nam EJ, Kim SW, Kim S, Kim YT.

Cancer Med. 2019 Feb;8(2):564-571. doi: 10.1002/cam4.1956. Epub 2019 Jan 16.

6.

Distinct Clinical Courses of Epithelial Ovarian Cancer with Mutations in BRCA1 5' and 3' Exons.

Eoh KJ, Park HS, Park JS, Lee ST, Han JW, Lee JY, Kim S, Kim SW, Kim YT, Nam EJ.

Anticancer Res. 2018 Dec;38(12):6947-6953. doi: 10.21873/anticanres.13073.

PMID:
30504414
8.

Prognostic significance of supradiaphragmatic lymph node metastasis detected by 18F-FDG PET/CT in advanced epithelial ovarian cancer.

Lee IO, Lee JY, Kim HJ, Nam EJ, Kim S, Kim SW, Lee CY, Kang WJ, Kim YT.

BMC Cancer. 2018 Nov 26;18(1):1165. doi: 10.1186/s12885-018-5067-1.

9.

Genetic Profiles Associated with Chemoresistance in Patient-Derived Xenograft Models of Ovarian Cancer.

Li LY, Kim HJ, Park SA, Lee SH, Kim LK, Lee JY, Kim S, Kim YT, Kim SW, Nam EJ.

Cancer Res Treat. 2018 Nov 6. doi: 10.4143/crt.2018.405. [Epub ahead of print]

10.

Prognostic significance of CA-125 re-elevation after interval debulking surgery in patients with advanced-stage ovarian cancer undergoing neoadjuvant chemotherapy.

Lee YJ, Chung YS, Lee JY, Nam EJ, Kim SW, Kim S, Kim YT.

Eur J Surg Oncol. 2019 Apr;45(4):644-649. doi: 10.1016/j.ejso.2018.10.053. Epub 2018 Oct 11.

PMID:
30337203
11.

Expression of programmed cell death ligand 1 and immune checkpoint markers in residual tumors after neoadjuvant chemotherapy for advanced high-grade serous ovarian cancer.

Kim HS, Kim JY, Lee YJ, Kim SH, Lee JY, Nam EJ, Kim S, Kim SW, Kim YT.

Gynecol Oncol. 2018 Dec;151(3):414-421. doi: 10.1016/j.ygyno.2018.08.023. Epub 2018 Oct 9.

PMID:
30314669
12.

Factors Related with Utilizing Hospice Palliative Care Unit among Terminal Cancer Patients in Korea between 2010 and 2014: a Single Institution Study.

Park SJ, Nam EJ, Chang YJ, Lee YJ, Jho HJ.

J Korean Med Sci. 2018 Sep 10;33(41):e263. doi: 10.3346/jkms.2018.33.e263. eCollection 2018 Oct 8.

13.

Prediction of perioperative complications after robotic-assisted radical hysterectomy for cervical cancer using the modified surgical Apgar score.

Park SH, Lee JY, Nam EJ, Kim S, Kim SW, Kim YT.

BMC Cancer. 2018 Sep 21;18(1):908. doi: 10.1186/s12885-018-4809-4.

14.

Two-step sentinel lymph node mapping strategy in endometrial cancer staging using fluorescent imaging: A novel sentinel lymph node tracer injection procedure.

Eoh KJ, Lee YJ, Kim HS, Lee JY, Nam EJ, Kim S, Kim YT, Kim SW.

Surg Oncol. 2018 Sep;27(3):514-519. doi: 10.1016/j.suronc.2018.07.001. Epub 2018 Jul 2.

PMID:
30217312
15.

Periumbilical infiltration of lidocaine with epinephrine for postoperative pain reduction in single-port laparoscopic adnexal surgery.

Eoh KJ, Lee JY, Nam EJ, Kim S, Kim YT, Kim SW.

J Obstet Gynaecol. 2018 Nov;38(8):1135-1139. doi: 10.1080/01443615.2018.1455079. Epub 2018 Sep 12.

PMID:
30207501
16.

Evaluation of various kinetic parameters of CA-125 in patients with advanced-stage ovarian cancer undergoing neoadjuvant chemotherapy.

Lee YJ, Lee IH, Kim YJ, Chung YS, Lee JY, Nam EJ, Kim S, Kim SW, Kim YT.

PLoS One. 2018 Sep 6;13(9):e0203366. doi: 10.1371/journal.pone.0203366. eCollection 2018.

17.

Outcomes of Non-High Grade Serous Carcinoma after Neoadjuvant Chemotherapy for Advanced-Stage Ovarian Cancer: Single-Institution Experience.

Chung YS, Lee JY, Kim HS, Nam EJ, Kim SW, Kim YT.

Yonsei Med J. 2018 Oct;59(8):930-936. doi: 10.3349/ymj.2018.59.8.930.

18.

Aberrant uterine leiomyomas with extrauterine manifestation: intravenous leiomyomatosis and benign metastasizing leiomyomas.

Kim YN, Eoh KJ, Lee JY, Nam EJ, Kim S, Kim SW, Kim YT.

Obstet Gynecol Sci. 2018 Jul;61(4):509-519. doi: 10.5468/ogs.2018.61.4.509. Epub 2018 Jun 18.

19.

Impact of increased utilization of neoadjuvant chemotherapy on survival in patients with advanced ovarian cancer: experience from a comprehensive cancer center.

Lee YJ, Chung YS, Lee JY, Nam EJ, Kim SW, Kim S, Kim YT.

J Gynecol Oncol. 2018 Jul;29(4):e63. doi: 10.3802/jgo.2018.29.e63. Epub 2018 Apr 18.

20.

Physicians' attitudes towards the media and peer-review selection of the 'best cancer doctor': comparison of two different selection methods.

Shin DW, Cho J, Yang HK, Kim SY, Lee S, Nam EJ, Chung JS, Im JS, Park K, Park JH.

BMJ Open. 2018 May 14;8(5):e019067. doi: 10.1136/bmjopen-2017-019067.

21.

Difference in Risk of Breast and Ovarian Cancer According to Putative Functional Domain Regions in Korean BRCA1/2 Mutation Carriers.

Park JS, Lee ST, Han JW, Kim TI, Nam EJ, Park HS.

Clin Breast Cancer. 2018 Oct;18(5):362-373.e1. doi: 10.1016/j.clbc.2018.02.007. Epub 2018 Feb 20.

PMID:
29673794
22.

In-bag power morcellation technique in single-port laparoscopic myomectomy.

Won YB, Lee HJ, Eoh KJ, Chung YS, Lee YJ, Park SH, Kim JW, Lee JY, Nam EJ, Kim S, Kim YT, Kim SW.

Obstet Gynecol Sci. 2018 Mar;61(2):267-273. doi: 10.5468/ogs.2018.61.2.267. Epub 2018 Feb 2.

23.

Exposure of kale root to NaCl and Na2SeO3 increases isothiocyanate levels and Nrf2 signalling without reducing plant root growth.

Kim SY, Park JE, Kim EO, Lim SJ, Nam EJ, Yun JH, Yoo G, Oh SR, Kim HS, Nho CW.

Sci Rep. 2018 Mar 5;8(1):3999. doi: 10.1038/s41598-018-22411-9.

24.

MicroRNA-630 inhibitor sensitizes chemoresistant ovarian cancer to chemotherapy by enhancing apoptosis.

Eoh KJ, Lee SH, Kim HJ, Lee JY, Kim S, Kim SW, Kim YT, Nam EJ.

Biochem Biophys Res Commun. 2018 Mar 4;497(2):513-520. doi: 10.1016/j.bbrc.2018.02.062. Epub 2018 Feb 13.

PMID:
29452092
25.

Can simple trachelectomy or conization show comparable survival rate compared with radical trachelectomy in IA1 cervical cancer patients with lymphovascular space invasion who wish to save fertility? A systematic review and guideline recommendation.

Shim SH, Lim MC, Kim HJ, Lee M, Nam EJ, Lee JY, Lee YY, Lee KB, Park JY, Kim YH, Ki KD, Song YJ, Chung HH, Kim S, Lee JW, Kim JW, Bae DS, Lee JM.

PLoS One. 2018 Jan 31;13(1):e0189847. doi: 10.1371/journal.pone.0189847. eCollection 2018.

26.

Variants of cancer susceptibility genes in Korean BRCA1/2 mutation-negative patients with high risk for hereditary breast cancer.

Park JS, Lee ST, Nam EJ, Han JW, Lee JY, Kim J, Kim TI, Park HS.

BMC Cancer. 2018 Jan 16;18(1):83. doi: 10.1186/s12885-017-3940-y.

27.

Perioperative Outcomes of 3-Arm Versus 4-Arm Robotic Radical Hysterectomy in Patients with Cervical Cancer.

Yim GW, Eoh KJ, Chung YS, Kim SW, Kim S, Nam EJ, Lee JY, Kim YT.

J Minim Invasive Gynecol. 2018 Jul - Aug;25(5):823-831. doi: 10.1016/j.jmig.2017.12.009. Epub 2017 Dec 26.

PMID:
29287717
28.

Impact of the time interval from completion of neoadjuvant chemotherapy to initiation of postoperative adjuvant chemotherapy on the survival of patients with advanced ovarian cancer.

Lee YJ, Chung YS, Lee JY, Nam EJ, Kim SW, Kim S, Kim YT.

Gynecol Oncol. 2018 Jan;148(1):62-67. doi: 10.1016/j.ygyno.2017.11.023. Epub 2017 Nov 22.

PMID:
29174056
29.

Upregulation of homeobox gene is correlated with poor survival outcomes in cervical cancer.

Eoh KJ, Kim HJ, Lee JY, Nam EJ, Kim S, Kim SW, Kim YT.

Oncotarget. 2017 Sep 16;8(48):84396-84402. doi: 10.18632/oncotarget.21041. eCollection 2017 Oct 13.

30.
31.

Comparison of Clinical Features and Outcomes in Epithelial Ovarian Cancer according to Tumorigenicity in Patient-Derived Xenograft Models.

Eoh KJ, Chung YS, Lee SH, Park SA, Kim HJ, Yang W, Lee IO, Lee JY, Cho H, Chay DB, Kim S, Kim SW, Kim JH, Kim YT, Nam EJ.

Cancer Res Treat. 2018 Jul;50(3):956-963. doi: 10.4143/crt.2017.181. Epub 2017 Oct 17.

32.

Dysregulated expression of homeobox family genes may influence survival outcomes of patients with epithelial ovarian cancer: analysis of data from The Cancer Genome Atlas.

Eoh KJ, Kim HJ, Lee JY, Nam EJ, Kim S, Kim SW, Kim YT.

Oncotarget. 2017 Aug 1;8(41):70579-70585. doi: 10.18632/oncotarget.19771. eCollection 2017 Sep 19.

33.

Detection of Germline Mutations in Patients with Epithelial Ovarian Cancer Using Multi-gene Panels: Beyond BRCA1/2.

Eoh KJ, Kim JE, Park HS, Lee ST, Park JS, Han JW, Lee JY, Kim S, Kim SW, Kim JH, Kim YT, Nam EJ.

Cancer Res Treat. 2018 Jul;50(3):917-925. doi: 10.4143/crt.2017.220. Epub 2017 Sep 27.

34.

Impact of neoadjuvant chemotherapy and postoperative adjuvant chemotherapy cycles on survival of patients with advanced-stage ovarian cancer.

Chung YS, Kim YJ, Lee I, Lee JY, Nam EJ, Kim S, Kim SW, Kim YT.

PLoS One. 2017 Sep 5;12(9):e0183754. doi: 10.1371/journal.pone.0183754. eCollection 2017.

35.

External validation of chemotherapy response score system for histopathological assessment of tumor regression after neoadjuvant chemotherapy in tubo-ovarian high-grade serous carcinoma.

Lee JY, Chung YS, Na K, Kim HM, Park CK, Nam EJ, Kim S, Kim SW, Kim YT, Kim HS.

J Gynecol Oncol. 2017 Nov;28(6):e73. doi: 10.3802/jgo.2017.28.e73. Epub 2017 Jul 24.

36.

Transcatheter Arterial Embolization for Severe Secondary Hemorrhage after Hysterectomy.

Lee YJ, Kim MD, Lee JY, Kim SW, Kim SH, Kim YT, Nam EJ.

J Minim Invasive Gynecol. 2018 Jan;25(1):180-185. doi: 10.1016/j.jmig.2017.06.028. Epub 2017 Jul 13.

PMID:
28712795
37.

A novel algorithm for the treatment strategy for advanced epithelial ovarian cancer: consecutive imaging, frailty assessment, and diagnostic laparoscopy.

Eoh KJ, Yoon JW, Lee JY, Nam EJ, Kim S, Kim SW, Kim YT.

BMC Cancer. 2017 Jul 12;17(1):481. doi: 10.1186/s12885-017-3476-1.

38.

Syndecan-1 limits the progression of liver injury and promotes liver repair in acetaminophen-induced liver injury in mice.

Nam EJ, Hayashida K, Aquino RS, Couchman JR, Kozar RA, Liu J, Park PW.

Hepatology. 2017 Nov;66(5):1601-1615. doi: 10.1002/hep.29265. Epub 2017 Sep 26.

39.

The efficacy of systematic lymph node dissection in advanced epithelial ovarian cancer during interval debulking surgery performed after neoadjuvant chemotherapy.

Eoh KJ, Yoon JW, Lee I, Lee JY, Kim S, Kim SW, Kim YT, Nam EJ.

J Surg Oncol. 2017 Sep;116(3):329-336. doi: 10.1002/jso.24669. Epub 2017 May 22.

PMID:
28542980
40.

Sentinel lymph node mapping with indocyanine green in vaginal cancer.

Lee IO, Lee JY, Kim S, Kim SW, Kim YT, Nam EJ.

J Gynecol Oncol. 2017 Jul;28(4):e29. doi: 10.3802/jgo.2017.28.e29.

41.

Stepwise inhibition of T cell recruitment at post-capillary venules by orally active desulfated heparins in inflammatory arthritis.

Al Faruque H, Kang JH, Hwang SR, Sung S, Alam MM, Sa KH, Nam EJ, Byun YR, Kang YM.

PLoS One. 2017 Apr 18;12(4):e0176110. doi: 10.1371/journal.pone.0176110. eCollection 2017.

42.

Practice guidelines for management of cervical cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement.

Lim MC, Lee M, Shim SH, Nam EJ, Lee JY, Kim HJ, Lee YY, Lee KB, Park JY, Kim YH, Ki KD, Song YJ, Chung HH, Kim S, Lee JW, Kim JW, Bae DS, Lee JM.

J Gynecol Oncol. 2017 May;28(3):e22. doi: 10.3802/jgo.2017.28.e22. Epub 2017 Mar 15.

43.

Surgical technique for single-port laparoscopy in huge ovarian tumors: SW Kim's technique and comparison to laparotomy.

Kim JS, Lee IO, Eoh KJ, Chung YS, Lee I, Lee JY, Nam EJ, Kim S, Kim YT, Kim SW.

Obstet Gynecol Sci. 2017 Mar;60(2):178-186. doi: 10.5468/ogs.2017.60.2.178. Epub 2017 Mar 16.

44.

Endogenous inspired biomineral-installed hyaluronan nanoparticles as pH-responsive carrier of methotrexate for rheumatoid arthritis.

Alam MM, Han HS, Sung S, Kang JH, Sa KH, Al Faruque H, Hong J, Nam EJ, Kim IS, Park JH, Kang YM.

J Control Release. 2017 Apr 28;252:62-72. doi: 10.1016/j.jconrel.2017.03.012. Epub 2017 Mar 11.

PMID:
28288894
45.

Switching profiles in a population-based cohort of rheumatoid arthritis receiving biologic therapy: results from the KOBIO registry.

Park DJ, Choi SJ, Shin K, Kim HA, Park YB, Kang SW, Kwok SK, Kim SK, Nam EJ, Sung YK, Lee J, Lee CH, Jeon CH, Lee SS.

Clin Rheumatol. 2017 May;36(5):1013-1022. doi: 10.1007/s10067-017-3584-y. Epub 2017 Feb 27.

PMID:
28243760
46.

Delayed hemorrhage effect of local anesthesia with epinephrine in the loop electrosurgical excisional procedure.

Lee YJ, Park Y, Lee IO, Yoon JW, Lee JY, Kim SW, Kim S, Kim YT, Nam EJ.

Obstet Gynecol Sci. 2017 Jan;60(1):87-91. doi: 10.5468/ogs.2017.60.1.87. Epub 2017 Jan 19.

47.

A novel clinicopathological analysis of early stage ovarian Sertoli-Leydig cell tumors at a single institution.

Nam SM, Kim JW, Eoh KJ, Kim HM, Lee JY, Nam EJ, Kim S, Kim SW, Kim YT.

Obstet Gynecol Sci. 2017 Jan;60(1):39-45. doi: 10.5468/ogs.2017.60.1.39. Epub 2017 Jan 19.

48.

BRCA1 and BRCA2 mutation predictions using the BRCAPRO and Myriad models in Korean ovarian cancer patients.

Eoh KJ, Park JS, Park HS, Lee ST, Han J, Lee JY, Kim SW, Kim S, Kim YT, Nam EJ.

Gynecol Oncol. 2017 Apr;145(1):137-141. doi: 10.1016/j.ygyno.2017.01.026. Epub 2017 Feb 1.

PMID:
28159408
49.

Identification of a Novel BRCA1 Pathogenic Mutation in Korean Patients Following Reclassification of BRCA1 and BRCA2 Variants According to the ACMG Standards and Guidelines Using Relevant Ethnic Controls.

Park JS, Nam EJ, Park HS, Han JW, Lee JY, Kim J, Kim TI, Lee ST.

Cancer Res Treat. 2017 Oct;49(4):1012-1021. doi: 10.4143/crt.2016.433. Epub 2017 Jan 17.

50.

Outpatient Palliative Care and Aggressiveness of End-of-Life Care in Patients with Metastatic Colorectal Cancer.

Lee SW, Jho HJ, Baek JY, Shim EK, Kim HM, Ku JY, Nam EJ, Chang YJ, Choi HJ, Kim SY.

Am J Hosp Palliat Care. 2018 Jan;35(1):166-172. doi: 10.1177/1049909116689459. Epub 2017 Jan 19.

PMID:
28100061

Supplemental Content

Support Center